http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-583255-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0016
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate 1970-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-583255-A5
titleOfInvention Cardenolides and bufadienolides from oxime mixtures and 3-substitution - reaction - having inotropic activity with short latent time and short
abstract Cpds. of general formula (I) : (where A = groups A1-4 : R1 is H, hydroxy or acetoxy; R2 is hydroxy or acetoxy; R3 is prim., sec. or tert. amine, 2-oxo-3-oxazolidinyl or ureido; R4 is methyl or, when A = A1 where R1 = H, also hydroxymethyl, formyl or carb oxy; R5 (when R4 = hydroxymethyl, formyl or carboxy) = beta-hydroxy or beta-H, unless R4 = methyl and A = A1 with R1 = H, when R5 = alpha or beta-H) and their salts are prepd. from cpds. of formula (II) : (where X = (a) hydroxyimino or azido; (b) NH2; (c) Br or tosyloxy; (d) hydroxyethylamino); by (a) reducing to the amino gp.; (b) acylating, methylating, hydroxyethylating or carbamoylating the maino gp.; (c) reacting with a prim. or sec. amine, or (d) cyclisation to oxazolidinone. Prefd. cpds. (I) have substituents in posn. 3 in the beta-configuration.
priorityDate 1970-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11875334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53957771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21894497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449522968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451165845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453757922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456148107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455502157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453212194
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19096565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426565257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449603119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457780539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647

Total number of triples: 43.